A Day Up For iBio, Inc.
Tue, Jan 03, 2023 at 06:58 PM
iBio, Inc. (IBIO:NYSEMKT) soared at $0.66, representing a gain of 48.5%. On Tue, Jan 03, 2023, IBIO:NYSEMKT touched a New 2-Week High of $0.66. The stock got featured on our News Catalysts scanner on Fri, Dec 09, 2022 at 04:31 PM in the 'PUBLIC OFFERING' category. From Tue, Dec 20, 2022, the stock recorded 50.00% Up Days and 44.44% Green Days
About iBio, Inc. (IBIO:NYSEMKT)
iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.
Top 10 Gainers:
- Jasper Therapeutics Inc. (JSPR:NASDAQ), 476.36%
- Lucira Health Inc. (LHDX:NASDAQ), 440.05%
- Horizon Global Corporation (HZN:NYSE), 342.39%
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 84.08%
- Gelesis Holdings Inc. (GLS:NYSE), 79.06%
- Motorsport Games Inc. (MSGM:NASDAQ), 67.47%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 56.34%
- Viveve Medical, Inc. (VIVE:NASDAQ), 54.76%
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 49.39%
- iBio, Inc. (IBIO:NYSEMKT), 48.51%